S-ALPHA THERAPEUTICS
LIVE

Serial Number

79416915

Owner

S-Alpha Therapeutics, Inc.

Attorney

April L. Besl

Filing Date

Aug 7, 2024

Add to watchlist:

No watchlists yet
View on USPTO

S-ALPHA THERAPEUTICS Trademark

Serial Number: 79416915 • Registration: 8007187

S-ALPHA THERAPEUTICS is a trademark filed by S-Alpha Therapeutics, Inc. on August 7, 2024. The trademark is classified under Class 3 (Cosmetics & Cleaning), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

S-Alpha Therapeutics, Inc.

17th F., 311, Gangnam-daero, Seocho-gu

Entity Type: 03

Trademark Details

Filing Date

August 7, 2024

Registration Date

November 4, 2025

Published for Opposition

September 16, 2025

Goods & Services

Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; research and development of vaccines and medicines; providing information on the testing, inspection and research of medical products; scientific research in the fields of medicine, health and pharmacology; research and development of technology for medicinal chemical manufacturing; design of medical diagnostic apparatus and instruments; design services of manufacturing plants for the biotechnology industry; designing of medicinal chemicals manufacturing plants; design of equipment for chemical analysis; application service provider (ASP) featuring software for drug research; design, maintenance, rental and updating of computer software; platform as a service (PAAS) featuring computer software platforms for digital therapeutics; design, maintenance, rental and updating of software for use in the field of digital therapeutics; computer programming in the medical field; biotechnological research; research and development of technology for biotechnology; scientific research relating to chemistry; remote monitoring services for the functioning and use of medical diagnosis apparatuses; research and development of medical equipment; pharmaceutical product development

Disinfectants; sanitary preparations for medical purposes; pharmaceuticals for treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; vaccines; pharmacological preparations for skin care; steroids; chemical preparations for pharmaceutical purposes for treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; nutritional supplements; dietary and nutritional supplements; chemical preparations for medical or veterinary purposes for treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; medicated lotions and creams for the body, skin, face, and hands; medicated soap; detergents for medical purposes; dietetic beverages adapted for medical purposes; drugs for medical purposes for treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; pharmaceutical compositions for treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; pharmaceutical preparations for treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; nutraceutical preparations for treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; dietary supplements consisting of amino acids, minerals and trace elements

Wholesale store services featuring nutraceutical preparations for therapeutic or medical purposes; retail store services featuring nutraceutical preparations for therapeutic or medical purposes; advertising agency services for nutraceutical preparations for therapeutic or medical purposes; advisory services for business management; commercial assistance relating to system implementation and system integration; business administrative services for medical referrals; business management advice and assistance; conducting business research and surveys; market research consultancy; price comparison services; research services relating to advertising and marketing; providing consumer information relating to goods and services; import-export agency services; advertising agency services for medical apparatus and instruments; wholesale store services featuring medical apparatus; retail store services featuring medical apparatus; wholesale store services for computer hardware; retail store services for computer hardware; business intermediary services relating to matching of buyers and sellers by mail order by telecommunications; promoting the goods and services of others by means of operating an on-line comprehensive shopping mall

Essential oils; cosmetics; functional cosmetics being skin care preparations; anti-aging cosmetic preparations; cosmetic preparations for the hair and scalp; beauty creams; non-medicated skin care lotions; eye cream; mask packs for cosmetic purposes; face and body creams; cosmetic preparations for skin renewal; cosmetic preparations for baths; fragrances for personal use; cosmetic massage creams; non-medicated toiletry preparations; deodorants for human beings or for animals; body washes; shampoos; hand cleansers; pre-moistened cleansing tissues

DNA chips; bio-chips for research or scientific purposes; dosage dispensers for measuring and dispensing portions of fluids, powders, and solid granules, not for medical use; downloadable and recorded software for treating and managing diseases in the field of digital therapeutics; downloadable and recorded computer software for diagnosing diseases for medical purposes; downloadable and recorded software for recording, processing, analyzing, and transmitting medical data in the field of healthcare; downloadable and recorded computer software for use in medical decision support systems; downloadable and recorded computer software to maintain and operate computer systems; downloadable software application for database management; downloadable and recorded computer software for digital information and data access; downloadable and recorded computer software for application and database integration; computer hardware and computer peripheral devices; data communications computer hardware; computer networking hardware; optical inspecting apparatus and instruments for LCD; optical inspecting apparatus and instruments; blank digital data storage media; alarm monitoring apparatus, other than for medical purposes; downloadable computer application software for database management for healthcare, for smartphones; downloadable and recorded computer software for making electronic charts, for medical purposes

Clinical medical consultancy in the field of pharmaceutical and medical products; clinical medical information services in the field of medical products; dispensing services of nutritional supplements for medical purposes; medical consultancy for selecting appropriate medicines; medical information services provided via the Internet; medical and health care services; telemedicine services; medical clinic services; providing information in the field of medicine; professional consultancy in the field of health care; advisory services relating to health; health care; physical examination services; psychological counselling and therapy; nutritional and dietetic consultancy; health care advisory services relating to medical apparatus and instruments; medical analysis services; provision of medical services; provision of information in the field of medicine; medical research services relating to clinical data

Filing History

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Jul 30, 2026 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jul 13, 2026 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Jul 12, 2026 OPNR
FINAL DECISION TRANSACTION PROCESSED BY IB
Jun 11, 2026 FINO
FINAL DISPOSITION NOTICE SENT TO IB
May 21, 2026 FICS
FINAL DISPOSITION PROCESSED
May 21, 2026 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Feb 4, 2026 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Nov 4, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Nov 4, 2025 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 16, 2025 NPUB
PUBLISHED FOR OPPOSITION
Sep 16, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 10, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 19, 2025 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 13, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 13, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 13, 2025 TROA
REFUSAL PROCESSED BY IB
May 4, 2025 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Apr 15, 2025 RFCS
REFUSAL PROCESSED BY MPU
Apr 15, 2025 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Mar 8, 2025 RFCR
NON-FINAL ACTION WRITTEN
Mar 7, 2025 CNRT
ASSIGNED TO EXAMINER
Mar 1, 2025 DOCK
APPLICATION FILING RECEIPT MAILED
Feb 28, 2025 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 28, 2025 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Feb 28, 2025 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Feb 13, 2025 REPR